Venue: ETC Venues

Location: London, United Kingdom

Event Website

The 2nd annual Biotech and Money London 2016 event is a two-day congress providing the education, strategies and solutions you need to enable more effective funding, investment, business planning and partnering within your business.

HOW IT’S DIFFERENT

  • A qualified executive-level only audience
  • No CROs, CMOs or EQMs present
  • Innovative formats; no powerpoint
  • Content to match your investment lifecycle
  • Online showcases and company profiling
  • Qualified 1-2-1 partnering

WHO IS SPEAKING

Keynote speakers include:

  • Sir Chris Evans OBE, Chairman, Excalibur Group
  • Shaun Grady, Vice President, Business Development Operations, AstraZeneca
  • Luigi de la Corte, Head of WWBD, GlaxoSmithKline
  • Peter George, CEO, Clinigen
  • Darrin Disley, CEO, Horizon Discovery
  • Dan Mahony, Fund Manager, Polar Capital

8 REASONS TO ATTEND

  • Access capital. Find investors, funding sources and partners.
  • Leave with bold new ideas. No death by powerpoint.
  • Find the real sources of innovation. Meet the innovators, Inventors and entrepreneurs.
  • Real market insight: What’s driving UK bioscience? Find out here.
  • High calibre, qualified senior decision makers only. No EQMs, CROs or CMOs.
  • Brand new pharma and Medtech focus showcasing partnering opportunities.
  • Showcase your company. Slide deck on our exclusive online platform!
  • High powered networking, partnering and business development.

25% Discount Code: FMGLDN16

As Europe’s leading investment and biopartnering conference, BioTrinity is the nexus of a booming life sciences innovation ecosystem and provides a unique platform for R&D, global pharma and investor companies across the life sciences industry to achieve their business objectives; to secure funding, seek acquisition and in-licensing deals and grow their network.

BioTrinity is celebrating its 10 year anniversary in April 2016. To reflect the importance of this key industry event, the theme running through the programme is the ‘Vision for Life Sciences 2030’. The dedicated MediTrinity stream will also address the ‘Vision for Medtech 2030’.

The Redefining Early Stage Investments (RESI) Conference is an ongoing conference series that will be establishing a global circuit for early stage life sciences companies to source investors, create relationships, and eventually, get funding. The RESI conference focuses on the diverse breadth of early stage investors that LSN tracks, including Family Offices, Venture Philanthropy Funds, VCs, Angel Groups, Corporate Venture Capital Funds, and more. The RESI Partnering Forum allows fundraising executives to identify and book up to 16 meetings with life science investors who fit their company’s technology sector and stage of development. Additionally, through an expansive series of panels and workshops, attendees will have the chance to hear firsthand accounts from investors explaining their current investment mandates and process for identifying and qualifying candidates.

FREEMIND is pleased to announce its sponsorship and invite you to attend Venture Summit | New England being held on December 9th, 2015.

***Special discount – use discount code ” Freemindvip” and receive an additional 10% off of the registration fee!

Venture Summit | New England ™

December 9th, 2015 | Hilton, Boston Dedham

 Where Innovation Meets Capital

Friends,

Come meet, interact and network with more than 500 VCs, Corporate VCs, angel investors, investment bankers and CEOs of early stage and emerging growth companies at the prestigious Venture Summit | New England™ being held on December 9th, 2015 at the Hilton, Boston Dedham.

Whether you’re a startup seeking capital and exposure or an investor seeking new deals, the New England Venture Summit ™ presented by youngStartup Ventures – is one event you won’t want to miss.

A highly productive full-day venture conference, the New England Venture Summit is dedicated to showcasing early VCs, Corporate VCs and angel investors committed to funding venture backed, emerging and early stage companies.

This exclusive summit will feature a distinguished line up of more than 80 Investors on interactive panelspresentations by more than 90 Top Innovators seeking funding, and high-level networking opportunities.

Partial list of Speakers from 2014:

Eric Ahlgren, Senior Associate , Bessemer Venture Partners | Grant Allen, Senior Vice President, ABB Technology Ventures | Gil Beyda, Managing Partner, Genacast Ventures | Joe Blair, Associate, Chrysalix Energy Venture Capital | David Blumberg, Managing Partner, Blumberg Capital | Greg Bohlen, Managing General Partner, Union Grove Venture Partners | Nathaniel Brinn, CFO/Principal, Vital Financial | Daniel Burstein, Managing Partner, Millennium Technology Value Partners | Tanguy Chau, Principal, Formation 8 | Steven Chrust, Managing Director, Centripetal Capital Partners | Daniel Chui, Venture Development Manager, Verizon Ventures | Andrew Clapp, Managing Partner, Arctaris Capital Partners | David Donabedian, Vice President, AbbVie Biotech Ventures | James Dugan, CEO & Managing Partner, OCA Ventures | Imran Eba, Partner, Action Potential Venture Capital | Rami Elkhatib, General Partner, Acero Capital | Alison Ernst, Senior Investment Associate, Massachusetts Clean Energy Center | Tania Fernanzez, Ph.D, Founder, DreamCatcher Ventures | Kevin Ferro, CEO, Vatera Holdings | Stan Fung, Managing Director, FarSight Ventures | Eyal Geffen, Managing Partner  , Sky Ventures | Sven Harmsen, Principal, BASF Venture Capital | Amir Hasidim, CFO, Gefen Biomed Investments | Bosun Hau, Partner, MVM Life Science Partners | Laurence Hayward, Partner, Independence Equity | Ben Hemani, Analyst, Braemar Energy Ventures | Paul Howe, Partner, Oxbridge Capital LLP | Tetsuro Iwata, Senior Manager, MP Healthcare Venture Management | Sven Karlsson, Investment Associate, Massachusetts Clean Energy Center | Roman Kikta, Managing Partner, Mobility Ventures | Jak Knowles, Principal, MPM Capital | Carey Lai, Director, Intel Capital | Eddy Lee, Principal, Fenox venture Capital | Larry Li, Founding Partner, zPark Capital  | Ben Lin, Managing Partner, Great Oaks Venture Capital | Mike Lousteau, VP, General Counsel, I2BF Global Ventures | Jim Macdonald, Managing Director, First Analysis | Nurzhas Makishev, Managing Director , W Venture Partners | Alan Mattamana, Principal, Fairview Capital | Edward Meehan, Founder, Arcady Bay Partners | Fred Meyer, Partner, Benu BioVentures | Vincent Miles, Partner, Abingworth | David Miller, Executive Managing Director, Clean Energy Venture Group | Christopher Nyren, Founder  , Educated Ventures  | Jay Onda, Principal, DoCoMo Capital | Christine Primmer, Associate, SJF Ventures | Rami Rahal, Co-Founder and General Partner, Blue Cloud Ventures | Stewart Rauner, Managing Partner  , Broadband Associates LLC | Michael Rehberg, Venture Capital, The Dow Chemical Company | Lisa Rhoads, Managing Director, Easton Capital | Riley Rodgers, Analyst, Arctaris Capital Partners | Douglas Roth, , Connecticut Innovations | Praveen Sahay, Managing Director, Wave Equity Partners | Akhil Saklecha, Managing Director, Artiman Ventures | Dan Silverburg, Marketing, Macmillan New Ventures | Eric Steele, Vice President, Catalyst Investors   | Jason Tagler, Partner, Camden Partners | Sebastian Titz, Manager, New Ventures, 3M New Ventures | Tibor Toth, Managing Director of Investments, Massachusetts Clean Energy Center | Brent Traidman, General Partner, Fenox Venture Capital | Kathleen Utecht, Venture Partner, Core Innovation Capital | Geeta Vemuri, Senior Managing Director, Baxter Ventures | Sonali Vijayavargiya, Founder & Managing Director, Augment Ventures | David Ward, Managing Partner, MTI Ventures | Jan Westerhues, Investment Partner, Robert Bosch Venture Capital GmbH | Keith Witek, Corporate VP, Strategy and Corporate Development, AMD Ventures | Pieter Wolters, Managing Director, DSM Venturing & Licensing  | Tim Wright, General Partner, Grandbanks Capital and more.

FREEMIND has made special arrangements for our network to receive a special discount of 10% off of the registration fee!

To Register now and receive the special discount use the link below and enter discount code ” Freemindvip” http://bit.ly/1gJtxuJ

In addition to providing access to leading Investors, the conference will feature more than 60 pre-screened early stage and emerging growth companies seeking capital, and hardcore networking.

This conference will be attended by the best people in the industry. Please register early to avoid disappointment.

CALL FOR TOP INNOVATORS!

Get Noticed > Get Funded > Grow Faster

A select group of more than 90 Top Innovators from the Technology, Life Sciences, CleanTech and Edtech sectors will be chosen to present their breakthrough investment opportunities to an exclusive audience of Venture Capitalists, Private Investors, Investment Bankers, Corporate Investors, and Strategic Partners.

Apply to Present:

To be considered for one of the Top Innovator slots click here: http://www.youngstartup.com/newengland2015/present.php

Questions about presenting? email us at [email protected]

REGISTER NOW and Save!!

We hope you can join us for the exclusive forum.

FREEMIND  & youngStartup Ventures

To inquire about group rates, register by phone or for more information contact:

[email protected] Ventures at 212.202.1002 x200

Check out highlight from previous summits here: http://www.youngstartup.com/newengland2014/video.php

Venue: TKP New York Conference Center

Location (city and country): New York, US

Event Website

Biotech and Money New York provides the education, strategies and solutions executives need to enable more effective funding, investment, business planning, partnering and strategic decision making within their business.

It’s where life science meets money, investors meet deal flow and industry promote strategic collaborations.

Detailed summary:

Biotech and Money New York aims to provide genuine peer 2 peer knowledge sharing, networking and deal making opportunities between CxO level executives, and uncover new ideas to move the industry forward. At its heart is a mission to promote NYC and the region as a center for life science excellence and help build linkages and business opportunities between East Coast life science companies and capital.

The congress is a catalyst for dialogue, debate and deal making to help lead growth in life science and healthcare investment and the building of billion dollar businesses. The congress will help forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in in the industry.

The congress will help promote NYC as a center for life sciences, and provide a physical platform and forum for advancing translation and connecting innovative life science companies with capital and partnership opportunities.

HOW IT’S DIFFERENT

  • A qualified executive-level audience
  • Innovative formats; no powerpoint
  • Content to match your investment / partnering lifecycle
  • Online showcases and company profiling
  • Qualified 1-2-1 partnering
  • No CROs, CMOs or EQMs present

WHO IS SPEAKING

Keynote speakers include:

  • Marc Tessier-Lavigne, President, Rockefeller University
  • Michael Foley, Sanders Director, Tri-Institutional Therapeutics Discovery Institute & The Sanders Innovation and Education Initiative
  • Louis Walcer, ‪Director, Kevin M. McGovern Family Center for Venture Development in the Life Sciences, Cornell University
  • Tom Maniatis, Chairman of the Department of Biochemistry and Molecular Biophysics, and Director of Precision Medicine, Columbia University, and Cofounder, New York Genome Center
  • Susan Solomon, CEO, The NY Stem Cell Foundation
  • Todd Sherer, ‪CEO, The Michael J. Fox Foundation for Parkinson’s Research
  • Judy Dunn, VP, Global Head, Clinical Development, Roche

5 REASONS TO ATTEND

  1. Access capital. Find investors and suitable funding and financing sources
  2. Engage partners. Identify partners of choice and conduct deal making
  3. Generate new ideas. Learn from your peers and generations of successful executives
  4. Find new sources of innovation. Meet the innovators, inventors and entrepreneurs with commercial potential
  5. Network, partner and carry out business development with decision makers and c-level executives

 

 

Life Science Nation (LSN) and Johnson & Johnson Innovation, JLABS (JLABS) are inviting fundraising life science companies to attend the upcoming Redefining Early Stage Investments (RESI) Conference in Boston on September 16th.

 

The first RESI Conference took place on September 16, 2013, and two years later, following highly successful events in San Francisco and Houston, LSN returns to Boston for the sixth RESI Conference. With new and returning sponsors including Johnson & Johnson Innovation JLABS, Charles River Laboratories, McDermott Will & Emory, and Wuxi AppTec, this event is expected to be the largest RESI so far, with more content and more meetings than ever. Also, JLABS will be hosting a cocktail reception to wrap up the event.

 

About RESI

The RESI Conference brings together the most diverse group of early stage investors under one roof, including Family Offices, Venture Philanthropy Funds, VCs, Angel Groups, Corporate Venture Capital Funds, and more. The RESI Partnering Forum allows fundraising executives to identify and book up to 16 meetings with life science investors who fit their company’s technology sector and stage of development. This one day conference provides the highest ROI in the industry by bringing together innovative technology and active early stage investors looking to deploy capital.

Come say hello at our booth at the Bio International Convention taking place in Philadelphia – June 15 – 18, 2015.

Ram May-Ron, Managing Partner, FreeMind Group and Guy-Har-Chen, FreeMind’s Chief Analyst will be taking meetings throughout the day in the booth. Come by for an Espresso, or drop your card to win a giant whiskey! (3.5L Grants)

Ayal Ronen, Vice President, FreeMind Group and Jonathan Adalist from the Business Development team are also attending the event and primarily meeting with future clients in the Business Forum.

FreeMind Booth – 4259